Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant' [Biomaterials, 128 (2021), 121159].

Biomaterials·2026
Same author

Isolation of an Americium Complex Containing a Radical Ligand.

Journal of the American Chemical Society·2026
Same author

Palopegteriparatide for Adults with Chronic Hypoparathyroidism: Skeletal Dynamics Through 3 yr of the Phase 2 paTH Forward Trial.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Epidemiologic Characteristics and Management of Sepsis Among Previously Healthy Patients.

CHEST critical care·2025
Same author

Role of single photon emission computed tomography (SPECT/CT) in cervical spine surgery decision making.

Neurosurgical review·2025
Same author

Probing <i>f</i>-Block Covalency at the Limits of Hard-Metal/Soft-Ligand Interactions through Chalcogenoether Complexes.

Journal of the American Chemical Society·2025
Same journal

Intense Incidental F-18 DOPA Uptake in Low-grade Prostate Adenocarcinoma: A Potential Diagnostic Pitfall.

Clinical nuclear medicine·2026
Same journal

A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer.

Clinical nuclear medicine·2026
Same journal

Epileptogenic Brain Metastasis Early Positive on 18FDG PET/CT Compared to MRI.

Clinical nuclear medicine·2026
Same journal

Dural Manifestation of Langerhans Cell Histiocytosis​: Multimodality Imaging Approach.

Clinical nuclear medicine·2026
Same journal

Malignant Perivascular Epithelioid Cell Tumor (PEComa) of Left Adrenal Gland With Extensive Intravenous Tumor Thrombi: 18F-FDG PET/CT Findings.

Clinical nuclear medicine·2026
Same journal

18F-MFBG Uptake From Multiple Focal "Hot Spots" to Superscan in a Pediatric Patient With High-risk Neuroblastoma.

Clinical nuclear medicine·2026
See all related articles

Related Experiment Video

Updated: May 30, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Subclinical hyperthyroidism: current concepts and scintigraphic imaging.

Charles Intenzo1, Serge Jabbour, Jeffrey L Miller

  • 1Department of Radiology, Thomas Jefferson University, Philadelphia, PA 19107, USA. charles.intenzo@jefferson.edu

Clinical Nuclear Medicine
|August 10, 2011
PubMed
Summary
This summary is machine-generated.

Subclinical hyperthyroidism, characterized by low thyroid-stimulating hormone, increases risks for arrhythmias and osteoporosis. Identifying the cause via scintigraphy aids in managing this condition.

More Related Videos

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
03:41

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Related Experiment Videos

Last Updated: May 30, 2026

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions
05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
03:41

High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model

Published on: October 11, 2022

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Area of Science:

  • Endocrinology
  • Nuclear Medicine

Background:

  • Subclinical hyperthyroidism involves suppressed thyroid-stimulating hormone (TSH) with normal thyroid hormones.
  • It is linked to increased risks of supraventricular arrhythmias and osteoporosis.
  • Management strategies remain debated, balancing intervention versus watchful waiting.

Purpose of the Study:

  • To emphasize the importance of identifying the underlying cause of subclinical hyperthyroidism.
  • To highlight the role of scintigraphy in diagnosing the etiology of TSH suppression.

Main Methods:

  • Review of diagnostic approaches for subclinical hyperthyroidism.
  • Focus on the utility of thyroid scintigraphy in differentiating causes.

Main Results:

  • Thyroid scintigraphy is crucial for identifying the specific thyroid disorder causing subclinical hyperthyroidism.
  • Recognizing scan patterns aids in accurate diagnosis and subsequent patient management.

Conclusions:

  • Accurate diagnosis of the cause of subclinical hyperthyroidism is essential for appropriate patient care.
  • Thyroid scintigraphy is a key diagnostic tool for imaging specialists to facilitate management decisions.